Bernstein just threw fresh fuel on Eli Lilly's (LLY) never-ending rally, as the firm lifted its price target on the stock to $1,300 from $1,100. For perspective, that’s an 18% bump compared to the old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback